Feedback / Questions
Blincyto (blinatumomab) - Amgen
Evaluating the Therapeutic Potential of gamma delta T-cells and Blinatumomab in Extramedullary Leukemia
(ESGCT 2026)
-
Sep 11, 2026 -
Abstract #P0309;
No abstract available
Hematological Malignancies • Leukemia
https://www.esgctcongress.com/poster-list
Gauspasha Yusuf Deshmukh
Sep 11, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next